Four of 38 patients with non-Hodgkin’s lymphoma have seen the disease disappear following treatment, while five others saw reductions of 50 per cent in their tumours. While the trials were only carried out on patients with blood cancer, it is hoped the methods can be adapted to tackle other cancers. The drug, which could prove cheaper than (read more...)